BNP Paribas Financial Markets Buys 218,066 Shares of iShares Biotechnology ETF $IBB

Posted by on May 30th, 2026

BNP Paribas Financial Markets boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 11.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,133,461 shares of the financial services provider’s stock after purchasing an additional 218,066 shares during the period. BNP Paribas Financial Markets’ holdings in iShares Biotechnology ETF were worth $360,064,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Brighton Jones LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter valued at about $201,000. AQR Capital Management LLC bought a new stake in iShares Biotechnology ETF during the 1st quarter worth approximately $455,000. Millennium Management LLC increased its stake in iShares Biotechnology ETF by 140.8% during the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after purchasing an additional 143,893 shares in the last quarter. M&T Bank Corp increased its stake in iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after purchasing an additional 750 shares in the last quarter. Finally, Walleye Capital LLC increased its stake in iShares Biotechnology ETF by 26.8% during the 2nd quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock worth $589,000 after purchasing an additional 985 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ IBB opened at $172.18 on Friday. The business has a 50 day simple moving average of $169.35 and a 200 day simple moving average of $170.34. iShares Biotechnology ETF has a 52-week low of $120.33 and a 52-week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a $0.1218 dividend. This represents a $0.49 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Stories

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.